nimustine has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Suda, Y; Uemura, K | 1 |
| Fujibayashi, Y; Furukawa, T; Kado, H; Kawai, H; Kubota, T; Nakagawa, T; Takamatsu, S; Toyohara, J; Yonekura, Y | 1 |
2 other study(ies) available for nimustine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
[Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET].
Topics: Adolescent; Adult; Antineoplastic Agents; Brain; Brain Neoplasms; Carbon Radioisotopes; Cerebrovascular Circulation; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Nimustine; Oxygen Radioisotopes; Tegafur; Tomography, Emission-Computed | 1989 |
Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survival; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Glioma; Nimustine; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Treatment Outcome | 2006 |